COMPANY INFO

COMPANY INFO 2018-01-19T09:50:12+00:00

Defytime Science Ltd (Headquarters)

Defytime Science Ltd is a new company that is focused on discovering a radical cure to TEDS or Telomerase Enzyme Deficiency Syndrome.

This syndrome is present in some 100% of humans and can lead to arthritis Alzheimer’s,osteoporosis, cardiovascular disease, macular degeneration and many other age related diseases.

Until now, no one has been able to offer any tangible hope in eradicating these life debilitating conditions. Imagine a world where all of these are rarities.

[LEARN MORE]

Sierra Sciences,LLC (Research Team)

Sierra Sciences, LLC, an 11-year old Reno biotech company, with the goal of preventing and/or reversing cellular senescence, and ultimately curing diseases associated with human aging, including the aging process itself.

Their lab is located in the middle of Northern Nevada’s technology district! With over 10,000 square feet, their lab is a prominent state-of-the-art research center in the area.

[LEARN MORE]

Defytime Science Ltd (Headquarters)

Defytime Science Ltd is a new company that is focused on discovering a radical cure to TEDS or Telomerase Enzyme Deficiency Syndrome.

This syndrome is present in some 100% of humans and can lead to arthritis Alzheimer’s,osteoporosis, cardiovascular disease, macular degeneration and many other age related diseases.

Until now, no one has been able to offer any tangible hope in eradicating these life debilitating conditions. Imagine a world where all of these are rarities.

LEARN MORE

telomeres telomerase supplements bill andrews anti aging supplements

Sierra Sciences,LLC (Research Team)

Sierra Sciences, LLC, an 11-year old Reno biotech company, with the goal of preventing and/or reversing cellular senescence, and ultimately curing diseases associated with human aging, including the aging process itself.

Their lab is located in the middle of Northern Nevada’s technology district! With over 10,000 square feet, their lab is a prominent state-of-the-art research center in the area.

LEARN MORE

Research Team

Bill Andrews, Ph. D

Dr. Bill Andrews is the President and CEO of Sierra Sciences. As a scientist, athlete and executive, he continually pushes the envelope and challenges convention. He has been featured in Popular Science, The Today Show and numerous documentaries on the topic of life extension including, most recently, the movie The Immortalists in which he co-stars with Aubrey de Grey.

Since 1981, Bill Andrews has focused on finding ways to extend the human lifespan and healthspan through telomere maintenance. As one of the principal discoverers of both the RNA and protein components of human telomerase, Dr. Andrews was awarded 2nd place as “National Inventor of the Year” in 1997. He earned his Ph.D. in Molecular and Population Genetics at the University of Georgia in 1981. He has served as Senior Scientist at Armos Corporation and Codon Corporation, Director of Molecular Biology at Berlex Biosciences and at Geron Corporation, and Director of Technology Development at EOS Biosciences. He is also a named inventor on over 50+ US issued patents on telomerase and author of numerous scientific research studies published in peer reviewed scientific journals.

Bill is also an avid ultra-marathon runner. Born December 10, 1951, he regularly competes in 100k and 100+ mile runs often finishing at the top of his age group. These grueling races have taken him all over the world to race in some of the most extreme environments, from Death Valley to the Himalayas. His running is presently featured in the movie The High.

Bill Andrews, Ph. D, President & CEO
telomeres telomerase supplements bill andrews anti aging supplements Sierra Sciences Research Team Lonnie Klaich, Vice President of Finance & Administration

Lonnie Klaich leads the finance and administrative functions of Sierra Sciences. He is responsible for financial and government reporting, financial planning, budgeting, and human resources. Mr. Klaich is a financial and business planning professional who has held financial leadership roles in the health care industry for twenty-five years. These have ranged from Insurance company, to Hospital, to the largest Neurosurgery Group in Northern Nevada. He has also served time with the gaming industry and freight & logistics industry. Lonnie is graduate of the University of Nevada, Reno with Bachelors of Science degree focusing on Accounting & Finance.

Lonnie Klaich, Vice President of Finance & Administration

Laura Briggs received her B.S. degree in Nutrition in 1993 and her Ph.D. in Environmental Science and Health in 2000 from the University of Nevada, Reno. After a one-year post-doctoral position at UNR she joined Sierra Sciences in 2001. In addition to coordinating research and development at Sierra Sciences, Dr. Briggs is also currently serving as the biology Lab Coordinator for Truckee Meadows Community College (TMCC) and has collaborated on research projects at the V.A. Medical Center in Reno, Nevada.

Laura A. Briggs, Ph.D, Vice President of Research and Discovery
telomeres telomerase supplements bill andrews anti aging supplements Sierra Sciences Research Team Jonathan Greenwood, Director of Business Development

Jonathan Greenwood (Park) is Director of Business Development and CEO of Defytime Holdings Ltd., a Global marketing and trading company. After graduating from Architecture University, he became an entrepreneur between Antipodean and East Asia. In his 15 years global marketing sales experience, he built excellent clients from the Asian markets and a large network in the Southeast Asia market. His management skills and understanding of the region adds tremendous value in making Defytime & Sierra Science a world class anti-aging destination.

Jonathan Greenwood, Director of Business Development
telomeres telomerase supplements bill andrews anti aging supplements Sierra Sciences Research Team Lancer Brown, M.S. Program Director of Screening

Lancer Brown received his B.S. and M.S. degrees in Biotechnology in 2003 from the University of Nevada, Reno and was one of three students in the inaugural advanced BS/MS Biotechnology Program. He distinguished himself by being the first student to complete the program. Lancer came to Sierra Sciences as an intern while completing his degree. Following graduation, he joined Sierra Sciences full-time where he has proven to have remarkable ability to engineer genes and DNA. He has recently been promoted to program director of screening.

Lancer Brown, M.S, Program Director of Screening
telomeres telomerase supplements bill andrews anti aging supplements Sierra Sciences Research Team Sal Cumella, M.D. Medical Liason

Salvatore Cumella, M.D., is the Executive Vice President of LENCO Diagnostic Laboratory and the President and CEO of Cumella Professional Services, a public relations and consulting firm. He received his B.A. in Biology from George Washington University and graduated from the University of Monterrey Medical School. Dr. Cumella’s career has focused on community service by being involved as a political fundraiser and community activist. He has been the recipient of numerous honors and awards, including the Ellis Island Medal of Honor and “Man of the Year” for Italian Charities of America and the Federation of Italian-American Organizations. He was founder and president of Careers Thru Education, a private corporation devised to further educate students in medical allied health programs; he has served on the Board of the Forum’s Children of the World Foundation; and he now serves on the Executive Boards of ABRUD (American Brotherhood for the Disables) and SUB-B (Senior Umbrella Network of Brooklyn).

Sal Cumella, M.D. Medical Liason
telomeres telomerase supplements bill andrews anti aging supplements Sierra Sciences Research Team Federico Gaeta, Ph.D.

Dr. Gaeta identified the first potent, small molecule, inhibitors of human telomerase. He is the sole inventor of universal therapeutic cancer vaccine technologies based on telomerase, currently being evaluated in human clinical trials. Dr. Gaeta is an experienced executive with major pharmaceutical and biotechnology companies in the area of new drug discovery and development.

Federico Gaeta, Ph.D